Methods and reagents that generate a CD8 T cell immune response
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 5, 2008
Grant Date -
Oct 7, 2004
app pub date -
Apr 28, 2004
filing date -
Jun 9, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully